Feridoon Najmabadi

1.0k total citations
14 papers, 827 citations indexed

About

Feridoon Najmabadi is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, Feridoon Najmabadi has authored 14 papers receiving a total of 827 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Oncology and 2 papers in Physiology. Recurrent topics in Feridoon Najmabadi's work include Connective Tissue Growth Factor Research (4 papers), Cancer-related Molecular Pathways (4 papers) and RNA modifications and cancer (3 papers). Feridoon Najmabadi is often cited by papers focused on Connective Tissue Growth Factor Research (4 papers), Cancer-related Molecular Pathways (4 papers) and RNA modifications and cancer (3 papers). Feridoon Najmabadi collaborates with scholars based in United States, Canada and France. Feridoon Najmabadi's co-authors include Andrei L. Gartel, Angela L. Tyner, Eugene Goufman, Nissim Hay, Xin Ye, Bruce L. Riser, Darryl R. Peterson, Herman Yeger, Bernard Perbal and Senthil K. Radhakrishnan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Oncogene and Biochemical and Biophysical Research Communications.

In The Last Decade

Feridoon Najmabadi

14 papers receiving 819 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Feridoon Najmabadi United States 11 634 254 87 84 62 14 827
Tetsuya Kurosu Japan 18 473 0.7× 186 0.7× 97 1.1× 82 1.0× 85 1.4× 35 831
Gerald Schmid Austria 16 578 0.9× 387 1.5× 65 0.7× 145 1.7× 73 1.2× 27 889
Testa United States 11 436 0.7× 147 0.6× 90 1.0× 67 0.8× 77 1.2× 22 691
Luca Ruggiero Italy 6 575 0.9× 215 0.8× 67 0.8× 106 1.3× 31 0.5× 7 720
Olesya Chayka United Kingdom 12 378 0.6× 210 0.8× 93 1.1× 129 1.5× 33 0.5× 17 571
Gaelle del Castillo Spain 11 356 0.6× 259 1.0× 74 0.9× 98 1.2× 29 0.5× 14 611
Maozhen Tian United States 8 540 0.9× 364 1.4× 76 0.9× 179 2.1× 60 1.0× 8 760
Roger S. Jackson United States 11 392 0.6× 189 0.7× 55 0.6× 118 1.4× 76 1.2× 14 620
Doris Schneller Austria 11 565 0.9× 303 1.2× 88 1.0× 198 2.4× 80 1.3× 13 939
M. Taton Belgium 10 332 0.5× 180 0.7× 59 0.7× 65 0.8× 29 0.5× 17 635

Countries citing papers authored by Feridoon Najmabadi

Since Specialization
Citations

This map shows the geographic impact of Feridoon Najmabadi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feridoon Najmabadi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feridoon Najmabadi more than expected).

Fields of papers citing papers by Feridoon Najmabadi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feridoon Najmabadi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feridoon Najmabadi. The network helps show where Feridoon Najmabadi may publish in the future.

Co-authorship network of co-authors of Feridoon Najmabadi

This figure shows the co-authorship network connecting the top 25 collaborators of Feridoon Najmabadi. A scholar is included among the top collaborators of Feridoon Najmabadi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feridoon Najmabadi. Feridoon Najmabadi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Chlebeck, Peter J., Bret Verhoven, Feridoon Najmabadi, et al.. (2021). Interleukin‐10 and Transforming Growth Factor‐β Cytokines Decrease Immune Activation During Normothermic Ex Vivo Machine Perfusion of the Rat Liver. Liver Transplantation. 27(11). 1577–1591. 18 indexed citations
2.
Riser, Bruce L., et al.. (2014). Treatment with the Matricellular Protein CCN3 Blocks and/or Reverses Fibrosis Development in Obesity with Diabetic Nephropathy. American Journal Of Pathology. 184(11). 2908–2921. 32 indexed citations
3.
Riser, Bruce L., Narasimharao Bhagavathula, Patricia Perone, et al.. (2012). Gadolinium-induced fibrosis is counter-regulated by CCN3 in human dermal fibroblasts: a model for potential treatment of nephrogenic systemic fibrosis. Journal of Cell Communication and Signaling. 6(2). 97–105. 7 indexed citations
4.
Riser, Bruce L., et al.. (2010). CCN3/CCN2 regulation and the fibrosis of diabetic renal disease. Journal of Cell Communication and Signaling. 4(1). 39–50. 43 indexed citations
5.
Riser, Bruce L., et al.. (2009). CCN3 (NOV) Is a Negative Regulator of CCN2 (CTGF) and a Novel Endogenous Inhibitor of the Fibrotic Pathway in an in Vitro Model of Renal Disease. American Journal Of Pathology. 174(5). 1725–1734. 97 indexed citations
6.
Cooker, Laurinda A., et al.. (2007). TNF-α, but not IFN-γ, regulates CCN2 (CTGF), collagen type I, and proliferation in mesangial cells: possible roles in the progression of renal fibrosis. American Journal of Physiology-Renal Physiology. 293(1). F157–F165. 48 indexed citations
7.
Radhakrishnan, Senthil K., Feridoon Najmabadi, Andrea Haegebarth, et al.. (2004). Constitutive expression of E2F-1 leads to p21-dependent cell cycle arrest in S phase of the cell cycle. Oncogene. 23(23). 4173–4176. 88 indexed citations
8.
Gartel, Andrei L., Xin Ye, Eugene Goufman, et al.. (2001). Myc represses the p21 (WAF1/CIP1) promoter and interacts with Sp1/Sp3. Proceedings of the National Academy of Sciences. 98(8). 4510–4515. 333 indexed citations
9.
Gartel, Andrei L., Feridoon Najmabadi, Eugene Goufman, & Angela L. Tyner. (2000). A role for E2F1 in Ras activation of p21(WAF1/CIP1) transcription. Oncogene. 19(7). 961–964. 48 indexed citations
10.
Gartel, Andrei L., Eugene Goufman, Feridoon Najmabadi, & Angela L. Tyner. (2000). Sp1 and Sp3 activate p21 (WAF1/CIP1) gene transcription in the Caco-2 colon adenocarcinoma cell line. Oncogene. 19(45). 5182–5188. 68 indexed citations
11.
Murlas, Christopher G., Apoorva Sharma, Anil Gulati, & Feridoon Najmabadi. (1997). Interleukin-1β increases airway epithelial cell mitogenesis partly by stimulating endothelin-1 production. Lung. 175(2). 117–126. 10 indexed citations
12.
Murlas, Christopher G., Anil Gulati, Gurinder Singh, & Feridoon Najmabadi. (1995). Endothelin-1 Stimulates Proliferation of Normal Airway Epithelial Cells. Biochemical and Biophysical Research Communications. 212(3). 953–959. 29 indexed citations
13.
Giacomoni, Dario, Feridoon Najmabadi, & Sheldon Dray. (1990). Serine Proteinase Inhibitors Produced by Human Melanoma Cell Lines. Tumor Biology. 11(1-2). 39–50. 1 indexed citations
14.
Giacomoni, Dario, Shlomo Ben‐Efraim, Feridoon Najmabadi, & Sheldon Dray. (1990). Inhibitors of lymphocyte activation secreted by human melanoma cell lines. Medical Oncology and Tumor Pharmacotherapy. 7(4). 273–80. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026